血液の液体成分である血漿は、医療の分野で重要な役割を果たします。タンパク質、ホルモン、電解質、抗体で構成され、さまざまな治療用途にとって重要なリソースとして機能します。血漿は、幅広い症状の治療に使用されるため、医学的に重要な重要性を持っています。血漿に由来する血漿由来療法は、免疫疾患、出血性疾患、希少疾患の管理に不可欠であることが証明されています。免疫グロブリン、凝固因子、血漿由来のアルブミンなどの製品は、数え切れないほどの命を救い、患者の生活の質を向上させてきました。2022 年の世界の血漿市場は 351 億 4,000 万ドルと評価され、2028 年までに 565 億 5,000 万ドルに達すると予想されます。2022 年の世界の血漿市場には 5,475 万リットルが供給されました。
血漿市場は、2023年から2028年の予測期間中に8.25%のCAGRで成長すると予測されます。免疫不全などの生命を脅かす疾患の有病率の増加、高齢者人口の増加、血漿誘導体製品の採用の増加が、血漿市場を牽引するでしょう。さらに、血漿分画技術の進歩、血漿療法の利点に対する意識の高まり、個別化医療の可能性が、この分野の明るい見通しに貢献しています。
目次
Table of Contents
1. Executive Summary
2. Introduction
2.1 Blood Plasma: An Overview
2.1.1 Definition of Blood Plasma
2.2 Blood Plasma Segmentation: An Overview
2.2.1 Blood Plasma Segmentation
3. Global Market Analysis
3.1 Global Blood Plasma Market: An Analysis
3.1.1 Global Blood Plasma Market: An Overview
3.1.2 Global Blood Plasma Market by Value
3.1.3 Global Blood Plasma Market by Type (Immunoglobulin, Albumin, Coagulation Factors and Others)
3.1.4 Global Blood Plasma Market by Application (Immunodeficiency Diseases, Hypogammaglobulinemia, Hemophilia and Other)
3.1.5 Global Blood Plasma Market by End User (Hospitals, Clinics and Others)
3.1.6 Global Blood Plasma Market by Region (North America, Europe, Asia Pacific, and ROW)
3.2 Global Blood Plasma Market: Type Analysis
3.2.1 Global Blood Plasma Market by Type: An Overview
3.2.2 Global Immunoglobulin Blood Plasma Market by Value
3.2.3 Global Albumin Blood Plasma Market by Value
3.2.4 Global Coagulation Factors Blood Plasma Market by Value
3.2.5 Global Other Blood Plasma Types Market by Value
3.3 Global Blood Plasma Market: Application Analysis
3.3.1 Global Blood Plasma Market by Application: An Overview
3.3.2 Global Immunodeficiency Diseases Blood Plasma Market by Value
3.3.3 Global Hypogammaglobulinemia Blood Plasma Market by Value
3.3.4 Global Hemophilia Blood Plasma Market by Value
3.3.5 Global Other Blood Plasma Applications Market by Value
3.4 Global Blood Plasma Market: End User Analysis
3.4.1 Global Blood Plasma Market by End User: An Overview
3.4.2 Global Hospitals Blood Plasma Market by Value
3.4.3 Global Clinics Blood Plasma Market by Value
3.4.4 Global Other Blood Plasma End Users Market by Value
3.5 Global Blood Plasma Market Demand & Supply: An Analysis
3.5.1 Global Blood Plasma Market by Demand & Supply: An Overview
3.5.2 Global Blood Plasma Market by Demand
3.5.3 Global Blood Plasma Market by Supply
3.5.4 Global Blood Plasma Market Supply by Collection Type (Source and Recovered)
3.5.5 Global Source and Recovered Blood Plasma Market by Supply
4. Regional Market Analysis
4.1 North America Blood Plasma Market: An Analysis
4.1.1 North America Blood Plasma Market: An Overview
4.1.2 North America Blood Plasma Market by Value
4.1.3 North America Blood Plasma Market by Region (The US, Canada and Mexico)
4.1.4 The US Blood Plasma Market by Value
4.1.5 Canada Blood Plasma Market by Value
4.1.6 Mexico Blood Plasma Market by Value
4.2 Europe Blood Plasma Market: An Analysis
4.2.1 Europe Blood Plasma Market: An Overview
4.2.2 Europe Blood Plasma Market by Value
4.2.3 Europe Blood Plasma Market by Region (Germany, France, United Kingdom, Italy and Rest of the Europe)
4.2.4 Germany Blood Plasma Market by Value
4.2.5 France Blood Plasma Market by Value
4.2.6 United Kingdom Blood Plasma Market by Value
4.2.7 Italy Blood Plasma Market by Value
4.2.8 Rest of Europe Blood Plasma Market by Value
4.3 Asia Pacific Blood Plasma Market: An Analysis
4.3.1 Asia Pacific Blood Plasma Market: An Overview
4.3.2 Asia Pacific Blood Plasma Market by Value
4.3.3 Asia Pacific Blood Plasma Market by Region (China, Japan, India, and Rest of Asia Pacific)
4.3.4 China Blood Plasma Market by Value
4.3.5 Japan Blood Plasma Market by Value
4.3.6 India Blood Plasma Market by Value
4.3.7 Rest of Asia Pacific Blood Plasma Market by Value
4.4 Rest of the World Blood Plasma Market: An Analysis
4.4.1 Rest of the World Blood Plasma Market: An Overview
4.4.2 Rest of the World Blood Plasma Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Blood Plasma Market
5.1.2 Decreased Plasma Collections per Centre Due to COVID
5.1.3 Post COVID Scenario
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Demand for Immunoglobulin in Therapeutic Treatments
6.1.2 Increasing Plasma Centers and Plasma Collection
6.1.3 Aging Population
6.1.4 Rising Prevalence of Alpha-1 Antitrypsin Deficiency (AATD)
6.1.5 Rising Incidence of Hemophilia
6.2 Challenges
6.2.1 Availability of Alternatives
6.2.2 Regulatory and Safety Considerations
6.3 Market Trends
6.3.1 Explosive Growth of Cell & Gene Therapies in Development
6.3.2 Increasing Adoption of Therapeutic Plasma Exchange (TPE)
6.3.3 Expansion of Plasma Fractionation Facilities
7. Competitive Landscape
7.1 Global Blood Plasma Players by Market Share
7.2 Global Blood Plasma Market Players: Major Plasma-derived Drugs
7.3 The US Blood Plasma Market Players by Plasma Collection Centers
8. Company Profiles
8.1 CSL Limited
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategies
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Business Overview
8.2.2 Revenue by Therapeutic Area
8.2.3 Business Strategy
8.3 Grifols, S.A.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy
8.4 Baxter International Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategies
8.5 Kedrion Biopharma
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 ADMA Biologics, Inc.
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy
8.7 Octapharma
8.7.1 Business Overview
8.7.2 Business Strategy
8.8 LFB S.A.
8.8.1 Business Overview
8.8.2 Business Strategy
8.9 Taibang Biotech Group Inc. (China Biologic Products)
8.9.1 Business Overview
List of Figures
Figure 1: Plasma Collection Process
Figure 2: Blood Plasma Segmentation
Figure 3: Global Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 5: Global Blood Plasma Market by Type; 2022 (Percentage, %)
Figure 6: Global Blood Plasma Market by Application; 2022 (Percentage, %)
Figure 7: Global Blood Plasma Market by End User; 2022 (Percentage, %)
Figure 8: Global Blood Plasma Market by Region; 2022 (Percentage, %)
Figure 9: Global Immunoglobulin Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 10: Global Immunoglobulin Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 11: Global Albumin Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 12: Global Albumin Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 13: Global Coagulation Factors Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 14: Global Coagulation Factors Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 15: Global Other Blood Plasma Types Market by Value; 2018-2022 (US$ Billion)
Figure 16: Global Other Blood Plasma Types Market by Value; 2023-2028 (US$ Billion)
Figure 17: Global Immunodeficiency Diseases Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 18: Global Immunodeficiency Diseases Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 19: Global Hypogammaglobulinemia Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 20: Global Hypogammaglobulinemia Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 21: Global Hemophilia Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 22: Global Hemophilia Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 23: Global Other Blood Plasma Applications Market by Value; 2018-2022 (US$ Billion)
Figure 24: Global Other Blood Plasma Applications Market by Value; 2023-2028 (US$ Billion)
Figure 25: Global Hospitals Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 26: Global Hospitals Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 27: Global Clinics Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 28: Global Clinics Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 29: Global Other Blood Plasma End Users Market by Value; 2018-2022 (US$ Billion)
Figure 30: Global Other Blood Plasma End Users Market by Value; 2023-2028 (US$ Billion)
Figure 31: Global Blood Plasma Market by Demand; 2018-2022 (Million Liters)
Figure 32: Global Blood Plasma Market by Demand; 2023-2028 (Million Liters)
Figure 33: Global Blood Plasma Market by Supply; 2018-2022 (Million Liters)
Figure 34: Global Blood Plasma Market by Supply; 2023-2028 (Million Liters)
Figure 35: Global Blood Plasma Market Supply by Collection Type; 2022 (Percentage, %)
Figure 36: Global Source and Recovered Blood Plasma Market by Supply; 2018-2022 (Million Liters)
Figure 37: Global Source and Recovered Blood Plasma Market by Supply; 2023-2028 (Million Liters)
Figure 38: North America Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 39: North America Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 40: North America Blood Plasma Market by Region; 2022 (Percentage, %)
Figure 41: The US Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 42: The US Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 43: Canada Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 44: Canada Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 45: Mexico Blood Plasma Market by Value; 2018-2022 (US$ Million)
Figure 46: Mexico Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 47: Europe Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 48: Europe Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 49: Europe Blood Plasma Market by Region; 2022 (Percentage, %)
Figure 50: Germany Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 51: Germany Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 52: France Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 53: France Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 54: United Kingdom Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 55: United Kingdom Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 56: Italy Blood Plasma Market by Value; 2018-2022 (US$ Million)
Figure 57: Italy Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 58: Rest of Europe Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 59: Rest of Europe Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 60: Asia Pacific Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 61: Asia Pacific Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 62: Asia Pacific Blood Plasma Market by Region; 2022 (Percentage, %)
Figure 63: China Blood Plasma Market by Value, 2018-2022 (US$ Billion)
Figure 64: China Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 65: Japan Blood Plasma Market by Value, 2018-2022 (US$ Billion)
Figure 66: Japan Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 67: India Blood Plasma Market by Value, 2018-2022 (US$ Million)
Figure 68: India Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 69: Rest of Asia Pacific Blood Plasma Market by Value, 2018-2022 (US$ Billion)
Figure 70: Rest of Asia Pacific Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 71: Rest of the World Blood Plasma Market by Value; 2018-2022 (US$ Billion)
Figure 72: Rest of the World Blood Plasma Market by Value; 2023-2028 (US$ Billion)
Figure 73: Global Plasma Centre Collections Growth Rate, 2011-2019 & 2019-2021 (Percentage, %)
Figure 74: Global Immunoglobulin Demand (or Ig Volumes Distributed); 2016-2021 (Million Grams)
Figure 75: The US Plasma Collection Estimates; 2020-2025 (Million Liters)
Figure 76: The US Number of Plasma Centers; 2018-2021 (Units)
Figure 77: Global Percentage Of Population Aged 65 Years Or Over; 2022, 2030 & 2050 (Percentage, %)
Figure 78: The US Projected Cell Therapies Launches; 2021 & 2024 (Units)
Figure 79: The US Projected Gene Therapies Launches; 2021 & 2024 (Units)
Figure 80: Global Blood Plasma Players by Market Share; 2022 (Percentage, %)
Figure 81: The US Blood Plasma Market Players by Plasma Collection Centers; 2018-2021 (Units)
Figure 82: CSL Limited Revenue by Segments; 2022 (Percentage, %)
Figure 83: Takeda Pharmaceutical Company Limited Revenue by Therapeutic Area; 2023 (Percentage, %)
Figure 84: Grifols, S.A. Sales by Segments; 2022 (Percentage, %)
Figure 85: Baxter International Inc. Net Sales by Segments; 2022 (Percentage, %)
Figure 86: Kedrion Biopharma Revenue by Segment; 2022 (Percentage, %)
Figure 87: ADMA Biologics, Inc. Revenue by Segment; 2022 (Percentage, %)
Table 1: Global Blood Plasma Market Players: Major Plasma-derived Drugs
